---
title: "Lyka Labs Ltd (LYKALABS) — Share Price, Financials & Analysis"
symbol: "LYKALABS"
company: "Lyka Labs Ltd"
canonical: "https://tapetide.com/stocks/LYKALABS"
isin: "INE933A01014"
nse_symbol: "LYKALABS"
bse_code: "500259"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 300.51
generated_at: "2026-09-13T19:52:18.829Z"
---

# Lyka Labs Ltd (LYKALABS)

Canonical page: https://tapetide.com/stocks/LYKALABS

## Company

- **NSE Symbol:** LYKALABS
- **BSE Code:** 500259
- **ISIN:** INE933A01014
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1995-02-08
- **CEO:** Mr. Kunal Narendra Gandhi
- **Employees:** 499
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** lykalabs.com

## About

Incorporated in 1976, Lyka Labs Ltd is in the development, manufacture and marketing of quality finished dosages[1]

## Latest Price

- **Price:** ₹82.9
- **Change:** -1.3 (-1.54%)
- **Open:** ₹84
- **Day High:** ₹84
- **Day Low:** ₹82.8
- **Previous Close:** ₹84.2
- **Volume:** 8273
- **As Of:** 2026-09-11T09:45:07+00:00

## Key Fundamentals

Observed at 2026-09-11T04:42:26.107713Z.

- **Market Cap:** ₹300.51 Cr
- **Classification:** Microcap
- **P/E (reported):** -32.3
- **EPS (TTM):** ₹-2.5
- **Book Value:** ₹25.68
- **Price to Book:** 3.27
- **Dividend Yield:** 0%
- **ROE:** -11.49%
- **ROCE:** -7%
- **Debt to Equity:** 0.53
- **Revenue (yearly):** ₹131.9 Cr
- **Net Income:** ₹-10.4 Cr
- **EBITDA:** ₹0 Cr
- **52-Week High:** ₹101.9
- **52-Week Low:** ₹44.1
- **RSI (14):** 76.4

## Tapetide Score

- **Score:** 38 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 10.2 (of 4473 scored stocks)
- **Confidence:** 91%
- **Data coverage:** 81%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 21.62 | 9% |
| growth | 32.87 | 9% |
| momentum | 86.86 | 12% |
| ownership | 48.91 | 24% |
| quality | 43.75 | 22% |
| valuation | 27.41 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company's working capital requirements have reduced from 32.4 days to 22.7 days

### Weaknesses

- Stock is trading at 3.20 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 8.29% over past five years.
- Company has a low return on equity of -2.04% over last 3 years.
- Company might be capitalizing the interest cost

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 175.79% | 196.05% | -93.39% |
| ebitda margin growth | 186.21% | -99.93% | -99.93% | -99.98% |
| net income growth | 124.69% | -231.65% | -32% | 1% |
| revenue growth | 49.3% | -6.25% | 11% | 8% |
| roce | -137.52% | -167.7% | -310.84% | 19.52% |
| roe | -125.4% | -250% | -2.56% | -104.03% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 27.99 | 32.56 | 27.77 | 30.11 | 41.16 | 33.8 | 33.43 | 33.03 | 36.66 | 30.73 | 28.03 | 42.31 |
| Expenses | 23.82 | 25.69 | 25.75 | 26.4 | 36.21 | 28.61 | 29.35 | 29.35 | 39.2 | 29.08 | 34.48 | 37.76 |
| Operating Profit | 4.17 | 6.87 | 2.02 | 3.71 | 4.95 | 5.19 | 4.08 | 3.68 | -2.54 | 1.65 | -6.45 | 4.55 |
| OPM % | 14.9 | 21.1 | 7.27 | 12.32 | 12.03 | 15.36 | 12.2 | 11.14 | -6.93 | 5.37 | -23.01 | 10.75 |
| Other Income | -0.18 | 0.54 | 0.32 | 0.56 | 0.03 | 0.83 | 0.82 | 0.63 | 1.09 | 1.16 | 0.61 | 0.42 |
| Interest | 1.19 | 1.28 | 1.07 | 0.65 | 0.54 | 0.61 | 0.47 | 0.85 | 0.79 | 0.82 | 0.7 | 1.01 |
| Depreciation | 3.59 | 2.84 | 2.9 | 1.76 | 1.76 | 1.83 | 1.42 | 2.11 | 2.15 | 2.15 | 2.04 | 2.01 |
| Profit before tax | -0.79 | 3.29 | -1.63 | 1.86 | 2.68 | 3.58 | 3.01 | 1.35 | -4.39 | -0.16 | -8.58 | 1.95 |
| Tax % | -22.78 | 38.6 | 28.22 | 30.65 | 28.36 | 24.3 | 32.89 | 26.67 | -26.65 | -6.25 | -6.06 | -5.13 |
| Net Profit | -0.49 | 1.78 | -2.09 | 1.29 | 1.91 | 2.7 | 2.03 | 0.99 | -3.22 | -0.15 | -8.07 | 2.05 |
| EPS in Rs | -0.15 | 0.54 | -0.63 | 0.4 | 0.59 | 0.76 | 0.5 | 0.26 | -0.94 | 0 | -2.13 | 0.57 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 60 | 71 | 61 | 86 | 194 | 93 | 111 | 138 | 128 | 138 |
| Expenses | 63 | 73 | 65 | 67 | 93 | 76 | 95 | 121 | 132 | 141 |
| Operating Profit | -4 | -2 | -4 | 20 | 101 | 17 | 16 | 18 | -3 | -3 |
| OPM % | -6 | -2.7 | -6 | 23 | 52 | 18 | 14 | 13 | -2.7 | -2 |
| Other Income | 4 | 1 | -30 | 0 | -4 | -4 | 1 | 2 | 4 | 3 |
| Interest | 10 | 7 | 20 | 26 | 20 | 12 | 5 | 2 | 3 | 3 |
| Depreciation | 11 | 7 | 8 | 8 | 17 | 14 | 13 | 7 | 8 | 8 |
| Profit before tax | -20 | -15 | -62 | -14 | 59 | -13 | -1 | 11 | -12 | -11 |
| Tax % | -5 | -59 | 1 | -29 | 35 | 0 | 182 | 29 | -11 | — |
| Net Profit | -19 | -6 | -63 | -10 | 38 | -13 | -3 | 8 | -10 | -9 |
| EPS in Rs | -6.14 | -1.97 | -21.1 | -4.03 | 13.59 | -4.3 | -0.75 | 2.24 | -2.81 | -2.5 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 22 | 28 | 28 | 29 | 29 | 29 | 31 | 33 | 36 | 36 |
| Reserves | 16 | 21 | 15 | -43 | -54 | -15 | 15 | 35 | 69 | 57 |
| Borrowings | 126 | 113 | 96 | 141 | 163 | 130 | 75 | 59 | 39 | 49 |
| Other Liabilities | 88 | 67 | 76 | 73 | 52 | 42 | 31 | 30 | 32 | 33 |
| Total Liabilities | 252 | 229 | 216 | 200 | 190 | 186 | 152 | 157 | 176 | 175 |
| Fixed Assets | 133 | 116 | 108 | 105 | 98 | 94 | 68 | 58 | 85 | 87 |
| CWIP | 24 | 28 | 31 | 28 | 26 | 18 | 16 | 23 | 1 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 94 | 85 | 77 | 68 | 66 | 74 | 67 | 76 | 90 | 86 |
| Total Assets | 252 | 229 | 216 | 200 | 190 | 186 | 152 | 157 | 176 | 175 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 31 | 11 | 27 | 5 | 9 | 79 | 9 | 2 | 2 | 5 |
| Cash from Investing Activity | -13 | -3 | -4 | 0 | 0 | -6 | 7 | -9 | -12 | -9 |
| Cash from Financing Activity | -19 | -10 | -23 | 3 | -12 | -63 | -22 | 2 | 5 | 4 |
| Net Cash Flow | 0 | -3 | -1 | 9 | -3 | 10 | -5 | -6 | -5 | 0 |
| Free Cash Flow | 18 | 7 | 23 | 4 | 8 | 72 | 15 | -7 | -10 | -6 |
| CFO/OP | 143 | -318 | -1462 | -131 | 49 | 79 | 52 | 21 | 28 | -159 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 97 | 125 | 75 | 48 | 37 | 35 | 79 | 89 | 114 | 100 |
| Inventory Days | 90 | 139 | 65 | 69 | 41 | 56 | 68 | 78 | 82 | 99 |
| Days Payable | 266 | 301 | 216 | 192 | 141 | 96 | 91 | 98 | 98 | 122 |
| Cash Conversion Cycle | -79 | -37 | -75 | -76 | -63 | -5 | 55 | 68 | 97 | 76 |
| Working Capital Days | -357 | -735 | -265 | -242 | -118 | -121 | 0 | 23 | 51 | 23 |
| ROCE % | 9 | -8 | -5 | -6 | 10 | 61 | 5 | 4 | 10 | -6 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 54.81% | 54.81% | 54.81% | 58.1% | 58.1% | 58.1% | 58.16% | 58.16% | 58.16% | 58.16% | 58.16% | 58.45% |
| FIIs | 0.18% | 0% | 0.17% | 0.15% | 0.15% | 0.15% | 0.23% | 0.16% | 0.18% | 0.17% | 0.29% | 0.17% |
| DIIs | 0.41% | 0.41% | 0.88% | 0.75% | 0.67% | 0.67% | 0.67% | 0.67% | 0.67% | 0.67% | 0.67% | 0.66% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 35.49% | 34.32% | 33.9% | 31.67% | 32.06% | 32.13% | 31.18% | 31.41% | 31.52% | 31.42% | 31.06% | 31.18% |
| Others | 9.11% | 10.46% | 10.23% | 9.32% | 9.02% | 8.95% | 9.76% | 9.61% | 9.48% | 9.57% | 9.82% | 9.54% |
| No. of Shareholders | 26652 | 26422 | 25717 | 25716 | 28943 | 29099 | 28472 | 28189 | 27743 | 27155 | 26727 | 29369 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 2 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 79.14 | Buy |
| EMA (10) | 79.83 | Buy |
| SMA (20) | 75.84 | Buy |
| EMA (20) | 76.62 | Buy |
| SMA (50) | 70.4 | Buy |
| EMA (50) | 72.05 | Buy |
| SMA (100) | 67.2 | Buy |
| EMA (100) | 69.69 | Buy |
| SMA (200) | 67.8 | Buy |
| EMA (200) | 73.18 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 71.35 | Sell |
| MACD (12,26,9) | 3.77 | Buy |
| Stochastic (14,3,3) | 93.43 | Sell |
| ADX (14) | 30.1 | Buy |
| Williams %R (14) | -14.98 | Sell |
| ATR (14) | 2.02 | Neutral |
| ROC (12) | 11.28 | Buy |
| Stoch RSI (14) | 70.47 | Neutral |
| UO (7,14,28) | 74.99 | Sell |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1e4080a-41f9-43ea-bfcb-1bc8dc619af5.pdf) |
| 2026-08-11 | [Revised Press Release On Unaudited Financial Results For The Q1 June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=722cacf6-ae32-452a-bbd3-2e3b9361218a.pdf) |
| 2026-08-11 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a72ffd2-1ffc-4e22-b3e5-18ee527d1aa3.pdf) |
| 2026-08-10 | [Board Meeting Outcome for Outcome Of The Board Meeting Dated 10Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f00d0b0-13ef-4c4b-9ffe-b91f010bd8f4.pdf) |
| 2026-08-10 | [Press Release For Unaudited Financial Results Of Q1 June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b674560-8d85-4501-b9af-2713000c4660.pdf) |
| 2026-08-10 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93f7feec-1f66-41cf-917a-6ff07eaa30c1.pdf) |
| 2026-07-24 | [Board Meeting Intimation for Board Meeting To Be Held On Monday 10Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86c15f0d-0577-4c4b-ad69-9c882fdf93db.pdf) |
| 2026-07-20 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9254742-6b22-424b-ad0e-cc596ea3d511.pdf) |
| 2026-07-17 | [Letter Sent To Shareholders](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de02bea9-b705-42e9-8478-5fd1a7811ddc.pdf) |
| 2026-07-17 | [47Th AGM Of The Company To Be Held On Monday 10Th August 2026 At 12.30 PM Through Video Conferencing](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54340201-a25f-42ef-a85c-3d2457638cd7.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-10 | [Financial Results For June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0b054a9-7688-4da1-b0ba-f1e003be06a1.pdf) |
| 2026-05-25 | [Financial Results For 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a6686b6-a613-49fb-a9b8-04a32eb409b6.pdf) |
| 2026-01-29 | [Financial Results For The Quarter Ended 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=979e0742-7b5a-41f8-bb11-fa4a7b02ccdf.pdf) |
| 2025-11-12 | [Financial Results For The Quarter 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d4f516a-c6fa-48bb-b238-2e32e36fddb8.pdf) |
| 2025-08-01 | [Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c3cf427-1401-4f65-bcd0-1bae38da9f08.pdf) |
| 2025-05-26 | [Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March 2025 And Statement Of Assets And Liabilities (Standalone And Consolidated) As At 31St March 2025 Alongwith Auditors Report (Standalone And Consolid](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19eabdfd-f42c-413c-9658-2e1ce36f08d1.pdf) |
| 2025-02-04 | [Intimation Under Regulations 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (The SEBI Listing Regulations)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=550f2bf5-0c21-4654-9651-f62f8cd86dd0.pdf) |
| 2024-11-12 | [Intimation Under Regulations 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ( The SEBI Listing Regulations)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0420b4c-64d3-4c47-9b2d-adfb07340d2b.pdf) |
| 2024-08-09 | [Financial Results For The Quarter Ended 30.06.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89ebfa88-af64-4913-b6fe-19ef9c229e1f.pdf) |
| 2024-05-21 | [Financial Results For The Year Ended 31.03.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91013356-5103-4057-a5dd-c0b3e91dea87.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - NCLT-sanctioned amalgamation of Lyka Exports into Lyka Labs became effective on 8 April 2026; authorized capital rose to Rs.59 crore. | [Update On The Scheme Of Amalgamation 9 Apr - NCLT-sanctioned amalgamation of Lyka Exports into Lyka Labs became effective on 8 April 2026; authorized capital rose to Rs.59 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cff479a1-b9c5-4479-91f1-4fb1bd94297e.pdf) |
| 9 Apr - Lyka Labs clarified there is no material information behind recent share price movement. | [Clarification On Price Movement 9 Apr - Lyka Labs clarified there is no material information behind recent share price movement.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a1ae6784-8d48-451d-b2a9-af361d5724ee.pdf) |
| 6 Mar - Cost auditors Rajaram Madhav Walavalkar & Co. resigned effective 5 March 2026 for FY2025-26. | [Intimation Pursuant To Regulation 30 Of The SEBI (LODR) Regulations, 2015- Resignation Of Cost Auditors 6 Mar - Cost auditors Rajaram Madhav Walavalkar & Co. resigned effective 5 March 2026 for FY2025-26.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/537a7016-c597-4166-b5cc-342485f57d9a.pdf) |
| 31 Mar - Appointed M/s. Nidhi Subhash Tibrewala & Co. as Cost Auditor for FY2025-26 (vacancy) and FY2026-27 on 31-Mar-2026. | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 31St March, 2026 31 Mar - Appointed M/s. Nidhi Subhash Tibrewala & Co. as Cost Auditor for FY2025-26 (vacancy) and FY2026-27 on 31-Mar-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/40cec7d3-f276-4d05-836f-6ceb10b6c18f.pdf) |
| 30 Apr - Lyka Labs confirms it is not a Large Corporate as of 31 March 2026; outstanding borrowing Rs 20.15 crore. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Lyka Labs confirms it is not a Large Corporate as of 31 March 2026; outstanding borrowing Rs 20.15 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9c647493-5b07-4bc0-9acf-232a8919ba94.pdf) |
| 30 Apr - Lyka Labs confirms it is not a Large Corporate as of 31 March 2026; outstanding borrowing Rs 20.15 crore. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Lyka Labs confirms it is not a Large Corporate as of 31 March 2026; outstanding borrowing Rs 20.15 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9c647493-5b07-4bc0-9acf-232a8919ba94.pdf) |
| 30 Apr - India Ratings affirmed Lyka Labs' bank facilities at IND BBB+/Stable/IND A2; size reduced to INR 332.8 million. | [Announcement under Regulation 30 (LODR)-Credit Rating 30 Apr - India Ratings affirmed Lyka Labs' bank facilities at IND BBB+/Stable/IND A2; size reduced to INR 332.8 million.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3c2af202-730d-463c-af25-254acd68506b.pdf) |
| 30 Apr - India Ratings affirmed Lyka Labs' bank facilities at IND BBB+/Stable/IND A2; size reduced to INR 332.8 million. | [Announcement under Regulation 30 (LODR)-Credit Rating 30 Apr - India Ratings affirmed Lyka Labs' bank facilities at IND BBB+/Stable/IND A2; size reduced to INR 332.8 million.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3c2af202-730d-463c-af25-254acd68506b.pdf) |
| 29 Jan - Q3 (ended 31 Dec 2025) unaudited standalone/consolidated results; standalone PAT Rs 27.99 lakh; auditors unqualified. | [Financial Results For The Quarter Ended 31St December, 2025 29 Jan - Q3 (ended 31 Dec 2025) unaudited standalone/consolidated results; standalone PAT Rs 27.99 lakh; auditors unqualified.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/979e0742-7b5a-41f8-bb11-fa4a7b02ccdf.pdf) |
| 27 Mar - Trading window closed from 1 April 2026 until 48 hours after audited FY2026 results announcement. | [Closure of Trading Window 27 Mar - Trading window closed from 1 April 2026 until 48 hours after audited FY2026 results announcement.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4a5e7d6a-2426-4277-adaf-1e338e84ed2d.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2010 from nse](https://archives.nseindia.com/annual_reports/AR_LYKALABS_2009_2010_13042011115222.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ecf5111e-4129-4e99-884d-46e1b5e5a505.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8874b15e-f9e6-40af-907b-06717acf30e6.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7a0d2eb2-ee52-4e67-9d39-10da3c6f02d4.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500259/73607500259.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500259/68827500259.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500259/65724500259.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/500259/5002590319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/500259/5002590318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/500259/5002590317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:52:18.829Z.